Increased bone mineral turnover without increased glucose utilization in sclerotic and hyperplastic change in fibrous dysplasia

Annals of Nuclear Medicine

Volumn 12, Issue 3, 1998, Pages 153-155

  Toba, Masahiro ^a   Hayashida, Kohei ^a,c   Imakita, Satoshi ^a   Fukuchi, Kazuki ^a   Kume, Norihiko ^a   Shimotsu, Yoriko ^a   Cho, Ihnho ^a   Ishida, Yoshio ^a   Takamiya, Makoto ^a   Kumita, Shin Ichiro ^b  

^a National Cardiovascular Center

^b NIPPON MEDICAL SCHOOL   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Fibrous dysplasia; Fluorine 18 fluorodeoxyglucose; Positron emission tomography; Tc 99m hydroxymethylene diphosphonate

Indexed keywords

FLUORODEOXYGLUCOSE F 18; OXIDRONATE TECHNETIUM TC 99M;

ADULT; ARTICLE; BONE SCINTISCANNING; BONE TURNOVER; CASE REPORT; FACIAL BONE; FEMALE; FIBROUS DYSPLASIA; GLUCOSE UTILIZATION; HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031867941     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164781     Document Type: Article

References (11)

1. Dominguez R, Saucedo J, Fenstermacher M. MRI findings in osteofibrous dysplasia. Magn Reson Imag 7: 567-570, 1989.
2. Casselman JW, Jonge ID, Neyt L, Clercq CD, D'Hont G. MRI in craniofacial fibrous dysplasia. Neuroradiol 35: 234-237, 1993.
3. Jee WH, Choi KH, Choe BY, Park JM, Shinn KS. Fibrous dysplasia: MR imaging characteristics with radiopathologic correlation. Am J Radiol 167: 1523-1527, 1993.
4. Daffner RH, Kirks DR, Gehweiler JA, Heaston DK. Computed tomography of fibrous dysplasia. Am J Radiol 139: 943-948, 1982.
5. Machida K, Makita K, Nishikawa J, Ohtake T, Iio M. Scintigraphic manifestation of fibrous dysplasia. Clin Nucl Med 11: 426-429, 1986.
6. Johns WD, Gupta SM, Kayani N. Scintigraphic evaluation of polyostotic fibrous dysplasia. Clin Nucl Med 12: 627-631, 1987.
7. Kubota K, MatsuzawaT, Ito M, Ito K, Fujiwara T, Abe Y, et al. Lung tumor imaging by positron emission tomography using C-11 L-methionine. J Nucl Med 26: 37-42, 1985.
8. 18F] Fluorodeoxyglucose in brain tumors: A powerful diagnostic and prognostic tool. Invest Radiol 22: 360-371, 1986.
9. Coleman RE, Hoffman JM, Hanson MW, Sostman HD, Schold SC. Clinical application of PET for the evaluation of brain tumors. J Nucl Med 32: 616-622, 1991.
10. Kern KA, Brunetti A, Norton JA, Chang AE, Malawer M, Lack E, et al. Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med 29: 181-185, 1988.
11. Alder LP, Blair HF, Makley JT, Williams RP, Joyce MJ, Leisure G, et al. Noninvasive grading of musculoskeletal tumors using PET. J Nucl Med 32: 1508-1512, 1991.